This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MESOTHELIOMA_EXALLC for full statistics.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
C45
Hospital discharge: ICD-9
158|163
Hospital discharge: ICD-8
158|163
Cause of death: ICD-10
C45
Cause of death: ICD-9
158|163
Cause of death: ICD-8
158|163
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
905[0-3]
Cancer registry: Behaviour codes
3
3 out of 7 registries used, show all original rules.
369
Check minimum number of events None
369
Include endpoints None
369
Remove individuals based on genotype QC
356
C3_MESOTHELIOMA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF8
Parent code in ICD-10
C45-C49
Name in latin
Mesothelioma
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Mesothelioma
based on the number of shared cases.
Broader endpoints:
- Mesothelioma (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 356 | 83 | 273 |
| Unadjusted prevalence (%) | 0.09 | 0.04 | 0.15 |
| Mean age at first event (years) | 67.55 | 58.81 | 70.20 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_MESOTHELIOMA – Mesothelioma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Mesothelioma
↥Endpoint not on priority list, no data to show.